United Therapeutics (NASDAQ: UTHR) revenue
United Therapeutics reported revenue of $3,183m for fiscal 2025, 10.6% more than in fiscal 2024 ($2,877m). Since fiscal 2016 its revenue has grown by 99.1%, an average growth of 7.9% a year.
United Therapeutics has grown its revenue for 6 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2019, −11.0%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $3,183m | +10.6% | $1,493m | 46.9% |
| 2024 | $2,877m | +23.6% | $1,377m | 47.9% |
| 2023 | $2,328m | +20.2% | $1,185m | 50.9% |
| 2022 | $1,936m | +14.9% | $979.7m | 50.6% |
| 2021 | $1,686m | +13.6% | $555.9m | 33.0% |
| 2020 | $1,483m | +2.4% | $593.6m | 40.0% |
| 2019 | $1,449m | −11.0% | −$187.6m | −12.9% |
| 2018 | $1,628m | −5.7% | $805.4m | 49.5% |
| 2017 | $1,725m | +7.9% | $814.9m | 47.2% |
| 2016 | $1,599m | — | $1,062m | 66.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
United Therapeutics revenue compared with its sector
By revenue for its latest fiscal year, United Therapeutics ranks 85th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; United Therapeutics, 10.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 83rd | Veeva Systems | $3,195m | 16.3% |
| 84th | Brookdale Senior Living | $3,194m | 2.2% |
| 85th | United Therapeutics | $3,183m | 10.6% |
| 86th | Astrana Health | $3,182m | 56.4% |
| 87th | Waters | $3,165m | 7.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of United Therapeutics
- How much revenue did United Therapeutics make in fiscal 2025?
- United Therapeutics reported revenue of $3,183m for fiscal 2025, compared with $2,877m in fiscal 2024.
- How much has the revenue of United Therapeutics grown?
- Between fiscal 2016 and fiscal 2025 it went from $1,599m to $3,183m: 99.1% more, an average growth of 7.9% a year.
- What was the best year for revenue at United Therapeutics?
- Of its last 10 fiscal years, fiscal 2025, with $3,183m.
- Where does United Therapeutics rank in its sector by revenue?
- It ranks 85th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for United Therapeutics come from?
- From the annual report (Form 10-K) that United Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that United Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on United Therapeutics: the United Therapeutics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.